Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-015966
Filing Date
2025-05-12
Accepted
2025-05-12 09:06:44
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q crvo20250331_10q.htm   iXBRL 10-Q 775969
2 EXHIBIT 31.1 ex_815840.htm EX-31.1 10558
3 EXHIBIT 31.2 ex_815841.htm EX-31.2 10579
4 EXHIBIT 32.1 ex_815842.htm EX-32.1 4857
5 EXHIBIT 32.2 ex_815843.htm EX-32.2 4754
11 cervologo.jpg GRAPHIC 25228
  Complete submission text file 0001437749-25-015966.txt   4432543

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crvo-20250331.xsd EX-101.SCH 41950
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20250331_def.xml EX-101.DEF 278480
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20250331_lab.xml EX-101.LAB 245150
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20250331_pre.xml EX-101.PRE 301208
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crvo-20250331_cal.xml EX-101.CAL 23753
63 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250331_10q_htm.xml XML 615777
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 25932869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)